Hotline:
+ 49 (0) 2204 2918806

Market studies for category Cardiovascular

Items 1 to 10 of 730 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 73
  1. Net price*
    Year
  2. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Shigella Infections (Shigellosis) - Pipeline Review, H2 2013

    Global Markets Direct
    47 pages
    Global Markets Direct’s, 'Shigella Infections (Shigellosis) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Shigella Infections (Shigellosis), complete with latest updates, and special features on late-stage and discontinued
    Englisch | Zukunftsanalyse | SKU: 386240
  3. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Avastin (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022

    GlobalData
    58 pages
    The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic
    Englisch | Zukunftsanalyse | SKU: 388965
  4. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Cell Therapeutics, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    64 pages
    Global Market Direct’s pharmaceuticals report, “Cell Therapeutics, Inc. - Product Pipeline Review - 2013” provides data on the Cell Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
    Englisch | Zukunftsanalyse | SKU: 386304
  5. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Review, H1 2013

    Global Markets Direct
    54 pages
    Introduction Global Markets Direct’s, 'Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS), complete with latest
    Englisch | Report | SKU: 329683
  6. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Pre-Eclampsia - Pipeline Review, H2 2014

    Global Markets Direct
    50 pages
    Global Markets Direct’s, ‘Pre-Eclampsia - Pipeline Review, H2 2014’, provides an overview of the Pre-Eclampsia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pre-Eclampsia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechani
    Englisch | Zukunftsanalyse | SKU: 987671658
  7. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Charlesson LLC. - Product Pipeline Review - 2013

    Global Markets Direct
    24 pages
    Global Market Direct’s pharmaceuticals report, “Charlesson LLC. - Product Pipeline Review - 2013” provides data on the Charlesson LLC.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is
    Englisch | Zukunftsanalyse | SKU: 386368
  8. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Myasthenia Gravis – Pipeline Review, H1 2013

    Global Markets Direct
    59 pages
    Introduction Global Markets Direct’s, 'Myasthenia Gravis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Myasthenia Gravis, complete with latest updates, and special features on late-stage and discontinued projects. It also
    Englisch | Report | SKU: 329747
  9. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    27 pages
    Global Market Direct’s pharmaceuticals report, “Stemedica Cell Technologies, Inc. - Product Pipeline Review - 2013” provides data on the Stemedica Cell Technologies, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued a
    Englisch | Zukunftsanalyse | SKU: 386432
  10. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Encephalomyelitis - Pipeline Review, H2 2013

    Global Markets Direct
    56 pages
    Global Markets Direct’s, 'Encephalomyelitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Encephalomyelitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p
    Englisch | Zukunftsanalyse | SKU: 381376
  11. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Sentinext Therapeutics Sdn Bhd - Product Pipeline Review - 2013

    Global Markets Direct
    20 pages
    Global Market Direct’s pharmaceuticals report, “Sentinext Therapeutics Sdn Bhd - Product Pipeline Review - 2013” provides data on the Sentinext Therapeutics Sdn Bhd’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dor
    Englisch | Zukunftsanalyse | SKU: 386496

Items 1 to 10 of 730 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 73